Answers are grounded in this paper and cite their sources.
Research demonstrates that glycolysis inhibitors reduce trimethylamine in atherosclerosis, suggesting potential in gut barrier protection.
As a global driver of cardiovascular disease, atherosclerosis is linked to the accumulation of trimethylamine (TMA), a metabolite produced when gut microbiota metabolize dietary choline. However, current strategies targeting TMA...
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: